Clinical Trial Update: Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed or Refractory Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a regimen of carboplatin, etoposide, cyclophosphamide, and autologous bone marrow transplant in relapsed or refractory cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extragonadal Germ Cell Tumor
• Ovarian Cancer
• Testicular Germ Cell Tumor
• Unspecified Adult Solid Tumor Protocol Specific

Drugs mentioned

• Autologous bone marrow transplantation
• CARBOPLATIN (Carboplatin)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Etoposide (Etoposide)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Extragonadal Germ Cell Tumor, Ovarian Cancer | Phase 2 | Status: COMPLETED